Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Overview, history, and objectives of performance measurement
2001
Evaluating the quality of medical care
10.1111/j.1468-0009.2005.00397.x · 2005
Quality indicators for non-small cell lung cancer operations with use of a modified Delphi consensus process
10.1016/j.athoracsur.2014.03.001 · 2014
International standards of care in thoracic oncology: a narrative review of clinical quality indicators
10.1016/j.lungcan.2023.107421 · 2023
Unresolved referenced work
Kept as external metadata until matched
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
10.1183/09031936.00184308 · 2009
Does multidisciplinary team management improve clinical outcomes in NSCLC? A systematic review with meta-analysis JTO
2023
The lung cancer working party of the British Thoracic Society standards of care committee
1998
Unresolved referenced work
Kept as external metadata until matched
Revised ests guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
10.1093/ejcts/ezu028 · 2014
The American Association for Thoracic Surgery (AATS) 2023 expert consensus document: staging and multidisciplinary management of patients with early-stage non–small cell lung cancer
10.1016/j.jtcvs.2023.04.039 · 2023
Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
10.1378/chest.12-2355 · 2013
Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial
10.1097/jto.0b013e318220c912 · 2011
A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer
10.1016/j.jtcvs.2011.08.037 · 2011
Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration
10.1016/j.athoracsur.2010.06.052 · 2010
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer
10.1093/ejcts/ezaf329 · 2025
Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease
10.1016/j.athoracsur.2007.12.071 · 2008
Complications of lung resection and exercise capacity: a meta-analysis
10.1016/j.rmed.2007.02.012 · 2007
Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238
10.1097/jto.0b013e318074bba7 · 2007
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery after Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
10.1093/ejcts/ezy301 · 2019
Preoperative exercise training to prevent postoperative pulmonary complications in adults undergoing major surgery: a systematic review and meta-analysis with trial sequential analysis
10.1513/annalsats.202002-183oc · 2021
Video-assisted thoracoscopic or open lobectomy in early-stage lung cancer
10.1056/evidoa2100016 · 2022
Comparison of robot-assisted thoracic surgery versus video-assisted thoracic surgery in the treatment of lung cancer: a systematic review and meta-analysis of prospective studies
2023
Robotic-assisted versus video-assisted lobectomy for resectable non-small-cell lung cancer: the RVlob randomized controlled trial
10.1016/j.eclinm.2024.102707 · 2024
Segmentectomy versus Lobectomy in Small-Sized Peripheral Non-Small-Cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Open-Label, Phase 3, Randomised, Controlled, Non-Inferiority Trial
10.1016/s0140-6736(21)02333-3 · 2022
Lobar or sublobar resection for peripheral stage IA Non–small-cell lung cancer
10.1056/nejmoa2212083 · 2023
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group
10.1016/0003-4975(95)00537-u · 1995
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer
10.1016/j.ejcts.2006.08.008 · 2006
Association of pathologic nodal staging quality with survival among patients with non-small cell lung cancer after resection with curative intent
10.1001/jamaoncol.2017.2993 · 2018
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial
10.1016/j.jtcvs.2010.11.008 · 2011
Complete resection in lung cancer surgery: from definition to validation and beyond
10.1016/j.jtho.2020.09.006 · 2020
The IASLC lung cancer staging project: analysis of resection margin status and proposals for residual tumor descriptors for non–small cell lung cancer
10.1016/j.jtho.2019.10.019 · 2020
Unresolved referenced work
Kept as external metadata until matched
Vinorelbine plus cisplatin vs. observation in resected Non-Small-
2005
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10
10.1200/jco.2009.24.0333 · 2010
Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
10.1016/s1470-2045(06)70804-x · 2006
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
10.1016/s1470-2045(22)00518-6 · 2022
Perioperative pembrolizumab for early-stage Non–small-cell lung cancer
10.1056/nejmoa2302983 · 2023
Perioperative nivolumab in resectable lung cancer
10.1056/nejmoa2311926 · 2024
Perioperative durvalumab for resectable Non–small-cell lung cancer
10.1056/nejmoa2304875 · 2023
Patient-reported outcome measures in cancer care an updated systematic review and meta-analysis
10.1001/jamanetworkopen.2024.24793 · doi-reference
Enhanced recovery after thoracic surgery: systematic review and meta-analysis
10.1016/j.xjon.2021.07.007 · doi-reference
Alectinib in resected ALK -Positive Non–small-cell lung cancer
10.1056/nejmoa2310532 · doi-reference
Neoadjuvant osimertinib for resectable EGFR-mutated non–small cell lung cancer
10.1200/jco-25-00883 · doi-reference
Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer: updated results from the phase III randomized ADAURA trial
10.1200/jco.22.02186 · doi-reference
Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial
10.1001/jama.2023.24735 · doi-reference